| Symbol |
Name |
Standardized Value |
|
CRP
|
C-reactive protein, pentraxin-related
|
2.733
|
|
UPK3A
|
uroplakin 3A
|
2.615
|
|
ALB
|
albumin
|
2.591
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
2.585
|
|
REN
|
renin
|
2.543
|
|
KRT20
|
keratin 20, type I
|
2.453
|
|
KRT7
|
keratin 7, type II
|
2.449
|
|
UPK2
|
uroplakin 2
|
2.408
|
|
PAX2
|
paired box 2
|
2.376
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
2.293
|
|
KLK3
|
kallikrein-related peptidase 3
|
2.276
|
|
LCN2
|
lipocalin 2
|
2.222
|
|
SIX2
|
SIX homeobox 2
|
2.218
|
|
HOXB7
|
homeobox B7
|
2.19
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
2.188
|
|
UPK1B
|
uroplakin 1B
|
2.178
|
|
TBX18
|
T-box 18
|
2.169
|
|
CAGE1
|
cancer antigen 1
|
2.157
|
|
AFP
|
alpha-fetoprotein
|
2.15
|
|
GATA3
|
GATA binding protein 3
|
2.148
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
2.136
|
|
AVPR2
|
arginine vasopressin receptor 2
|
2.133
|
|
EYA1
|
EYA transcriptional coactivator and phosphatase 1
|
2.11
|
|
TGFB1
|
transforming growth factor, beta 1
|
2.109
|
|
PTH
|
parathyroid hormone
|
2.105
|
|
ACE
|
angiotensin I converting enzyme
|
2.099
|
|
CST3
|
cystatin C
|
2.089
|
|
WT1
|
Wilms tumor 1
|
2.082
|
|
PAX8
|
paired box 8
|
2.08
|
|
SYP
|
synaptophysin
|
2.074
|
|
HNF1B
|
HNF1 homeobox B
|
2.053
|
|
SLC12A1
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 1
|
2.035
|
|
MME
|
membrane metallo-endopeptidase
|
2.034
|
|
MAPK8IP1
|
mitogen-activated protein kinase 8 interacting protein 1
|
2.034
|
|
B2M
|
beta-2-microglobulin
|
2.005
|
|
PRTN3
|
proteinase 3
|
2.0
|
|
UPK1A
|
uroplakin 1A
|
1.994
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
1.989
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
1.983
|
|
F2
|
coagulation factor II (thrombin)
|
1.966
|
|
AVP
|
arginine vasopressin
|
1.959
|
|
CDX2
|
caudal type homeobox 2
|
1.95
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
1.947
|
|
INS
|
insulin
|
1.926
|
|
OGA
|
O-GlcNAcase
|
1.923
|
|
TSHZ3
|
teashirt zinc finger homeobox 3
|
1.922
|
|
CD68
|
CD68 molecule
|
1.911
|
|
AHR
|
aryl hydrocarbon receptor
|
1.909
|
|
TP53
|
tumor protein p53
|
1.895
|
|
SALL1
|
spalt-like transcription factor 1
|
1.892
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
1.879
|
|
KRT5
|
keratin 5, type II
|
1.879
|
|
WNT9B
|
wingless-type MMTV integration site family, member 9B
|
1.876
|
|
UMOD
|
uromodulin
|
1.864
|
|
ROBO2
|
roundabout, axon guidance receptor, homolog 2 (Drosophila)
|
1.86
|
|
BMP4
|
bone morphogenetic protein 4
|
1.86
|
|
KCNJ1
|
potassium channel, inwardly rectifying subfamily J, member 1
|
1.856
|
|
CD34
|
CD34 molecule
|
1.845
|
|
CD99
|
CD99 molecule
|
1.826
|
|
CHGA
|
chromogranin A
|
1.819
|
|
LHX1
|
LIM homeobox 1
|
1.817
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
1.815
|
|
FOXF1
|
forkhead box F1
|
1.813
|
|
ACTG2
|
actin, gamma 2, smooth muscle, enteric
|
1.812
|
|
MPO
|
myeloperoxidase
|
1.81
|
|
CD99L2
|
CD99 molecule-like 2
|
1.8
|
|
SHH
|
sonic hedgehog
|
1.796
|
|
GDNF
|
glial cell derived neurotrophic factor
|
1.787
|
|
SIX1
|
SIX homeobox 1
|
1.778
|
|
PKHD1
|
polycystic kidney and hepatic disease 1 (autosomal recessive)
|
1.775
|
|
CDH16
|
cadherin 16, KSP-cadherin
|
1.763
|
|
CD1A
|
CD1a molecule
|
1.763
|
|
HPSE2
|
heparanase 2 (inactive)
|
1.755
|
|
CD1E
|
CD1e molecule
|
1.751
|
|
EPO
|
erythropoietin
|
1.75
|
|
CD1B
|
CD1b molecule
|
1.744
|
|
NCAM1
|
neural cell adhesion molecule 1
|
1.732
|
|
FOXD1
|
forkhead box D1
|
1.726
|
|
HP
|
haptoglobin
|
1.724
|
|
PLA2R1
|
phospholipase A2 receptor 1, 180kDa
|
1.722
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
1.718
|
|
IL6
|
interleukin 6
|
1.715
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
1.678
|
|
EGF
|
epidermal growth factor
|
1.674
|
|
WNT4
|
wingless-type MMTV integration site family, member 4
|
1.671
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
1.671
|
|
CD1C
|
CD1c molecule
|
1.669
|
|
UPK3B
|
uroplakin 3B
|
1.659
|
|
CD4
|
CD4 molecule
|
1.655
|
|
CKM
|
creatine kinase, muscle
|
1.653
|
|
CKMT1B
|
creatine kinase, mitochondrial 1B
|
1.645
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
1.642
|
|
CKMT2
|
creatine kinase, mitochondrial 2 (sarcomeric)
|
1.642
|
|
CKB
|
creatine kinase, brain
|
1.638
|
|
SETBP1
|
SET binding protein 1
|
1.638
|
|
SCNN1G
|
sodium channel, non voltage gated 1 gamma subunit
|
1.625
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
1.617
|
|
MB
|
myoglobin
|
1.615
|
|
WNT11
|
wingless-type MMTV integration site family, member 11
|
1.614
|
|
FREM2
|
FRAS1 related extracellular matrix protein 2
|
1.607
|
|
BBS10
|
Bardet-Biedl syndrome 10
|
1.606
|
|
ATP12A
|
ATPase, H+/K+ transporting, nongastric, alpha polypeptide
|
1.606
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
1.606
|
|
GLI3
|
GLI family zinc finger 3
|
1.603
|
|
ATP4A
|
ATPase, H+/K+ exchanging, alpha polypeptide
|
1.602
|
|
CD1D
|
CD1d molecule
|
1.599
|
|
AGTR1
|
angiotensin II receptor, type 1
|
1.599
|
|
TNF
|
tumor necrosis factor
|
1.598
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
1.592
|
|
CD274
|
CD274 molecule
|
1.592
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
1.59
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
1.586
|
|
C3
|
complement component 3
|
1.585
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
1.584
|
|
ESR1
|
estrogen receptor 1
|
1.58
|
|
AGXT
|
alanine-glyoxylate aminotransferase
|
1.577
|
|
SIX5
|
SIX homeobox 5
|
1.577
|
|
AMBP
|
alpha-1-microglobulin/bikunin precursor
|
1.576
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
1.576
|
|
SDC1
|
syndecan 1
|
1.575
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
1.571
|
|
FOXC1
|
forkhead box C1
|
1.57
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
1.568
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
1.567
|
|
INSM1
|
insulinoma-associated 1
|
1.566
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
1.558
|
|
CALB2
|
calbindin 2
|
1.555
|
|
RET
|
ret proto-oncogene
|
1.551
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
1.55
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
1.549
|
|
FRAS1
|
Fraser extracellular matrix complex subunit 1
|
1.549
|
|
FN1
|
fibronectin 1
|
1.546
|
|
KIF12
|
kinesin family member 12
|
1.542
|
|
PGR
|
progesterone receptor
|
1.542
|
|
CALD1
|
caldesmon 1
|
1.536
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
1.536
|
|
BBS2
|
Bardet-Biedl syndrome 2
|
1.535
|
|
LRIG2
|
leucine-rich repeats and immunoglobulin-like domains 2
|
1.535
|
|
IFNA17
|
interferon, alpha 17
|
1.518
|
|
FOXI1
|
forkhead box I1
|
1.514
|
|
MYH11
|
myosin, heavy chain 11, smooth muscle
|
1.513
|
|
GPT2
|
glutamic pyruvate transaminase (alanine aminotransferase) 2
|
1.513
|
|
KRT8
|
keratin 8, type II
|
1.512
|
|
KDM6A
|
lysine (K)-specific demethylase 6A
|
1.512
|
|
NPHP1
|
nephronophthisis 1 (juvenile)
|
1.511
|
|
CD5
|
CD5 molecule
|
1.511
|
|
HCN3
|
hyperpolarization activated cyclic nucleotide gated potassium channel 3
|
1.509
|
|
SMIM20
|
small integral membrane protein 20
|
1.509
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
1.506
|
|
PIK3C2A
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
|
1.503
|
|
CD8A
|
CD8a molecule
|
1.498
|
|
POMC
|
proopiomelanocortin
|
1.496
|
|
MTHFSD
|
methenyltetrahydrofolate synthetase domain containing
|
1.494
|
|
IL1B
|
interleukin 1, beta
|
1.494
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
1.492
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
1.491
|
|
PIGV
|
phosphatidylinositol glycan anchor biosynthesis, class V
|
1.49
|
|
AQP3
|
aquaporin 3 (Gill blood group)
|
1.483
|
|
IFNA2
|
interferon, alpha 2
|
1.481
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
1.481
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
1.48
|
|
KAT6B
|
K(lysine) acetyltransferase 6B
|
1.477
|
|
WNT7B
|
wingless-type MMTV integration site family, member 7B
|
1.475
|
|
PIGW
|
phosphatidylinositol glycan anchor biosynthesis, class W
|
1.474
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
1.467
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
1.464
|
|
MYOG
|
myogenin (myogenic factor 4)
|
1.464
|
|
EGFR
|
epidermal growth factor receptor
|
1.459
|
|
PTHLH
|
parathyroid hormone-like hormone
|
1.459
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
1.457
|
|
ACTB
|
actin, beta
|
1.456
|
|
AMH
|
anti-Mullerian hormone
|
1.455
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
1.454
|
|
PCYT1A
|
phosphate cytidylyltransferase 1, choline, alpha
|
1.448
|
|
SPP1
|
secreted phosphoprotein 1
|
1.446
|
|
IFNG
|
interferon, gamma
|
1.445
|
|
CHD7
|
chromodomain helicase DNA binding protein 7
|
1.445
|
|
AGTR2
|
angiotensin II receptor, type 2
|
1.437
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
1.436
|
|
ALDH1A2
|
aldehyde dehydrogenase 1 family, member A2
|
1.436
|
|
PXDNL
|
peroxidasin-like
|
1.436
|
|
PXDN
|
peroxidasin
|
1.435
|
|
MUC1
|
mucin 1, cell surface associated
|
1.435
|
|
IFNA14
|
interferon, alpha 14
|
1.432
|
|
IFNA16
|
interferon, alpha 16
|
1.432
|
|
IFNA7
|
interferon, alpha 7
|
1.432
|
|
IFNA8
|
interferon, alpha 8
|
1.431
|
|
IFNA10
|
interferon, alpha 10
|
1.431
|
|
BBS1
|
Bardet-Biedl syndrome 1
|
1.431
|
|
IFNA6
|
interferon, alpha 6
|
1.431
|
|
IFNA21
|
interferon, alpha 21
|
1.431
|
|
IFNA5
|
interferon, alpha 5
|
1.43
|
|
ACD
|
adrenocortical dysplasia homolog (mouse)
|
1.428
|
|
IFNA13
|
interferon, alpha 13
|
1.428
|
|
HOGA1
|
4-hydroxy-2-oxoglutarate aldolase 1
|
1.427
|
|
IFNA4
|
interferon, alpha 4
|
1.426
|
|
TNXB
|
tenascin XB
|
1.425
|
|
PTPRN
|
protein tyrosine phosphatase, receptor type, N
|
1.424
|
|
KRT14
|
keratin 14, type I
|
1.422
|
|
DICER1
|
dicer 1, ribonuclease type III
|
1.421
|
|
DNAH8
|
dynein, axonemal, heavy chain 8
|
1.419
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
1.413
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
1.408
|
|
GFRA1
|
GDNF family receptor alpha 1
|
1.406
|
|
FOXC2
|
forkhead box C2
|
1.406
|
|
PIP
|
prolactin-induced protein
|
1.406
|
|
IFNA1
|
interferon, alpha 1
|
1.404
|
|
SLC7A9
|
solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9
|
1.402
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
1.399
|
|
PDPN
|
podoplanin
|
1.397
|
|
NF1
|
neurofibromin 1
|
1.396
|
|
IL10
|
interleukin 10
|
1.394
|
|
PAX5
|
paired box 5
|
1.392
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
1.391
|
|
GRHPR
|
glyoxylate reductase/hydroxypyruvate reductase
|
1.391
|
|
NPPB
|
natriuretic peptide B
|
1.39
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
1.389
|
|
ATP6V1B1
|
ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1
|
1.388
|
|
DKKL1
|
dickkopf-like 1
|
1.388
|
|
CLDN16
|
claudin 16
|
1.38
|
|
BMP7
|
bone morphogenetic protein 7
|
1.38
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1.375
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
1.375
|
|
CASR
|
calcium-sensing receptor
|
1.368
|
|
LRP2
|
low density lipoprotein receptor-related protein 2
|
1.365
|
|
MYH14
|
myosin, heavy chain 14, non-muscle
|
1.363
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
1.357
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
1.356
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
1.355
|
|
AR
|
androgen receptor
|
1.354
|
|
BBS12
|
Bardet-Biedl syndrome 12
|
1.353
|
|
GREB1L
|
growth regulation by estrogen in breast cancer-like
|
1.351
|
|
CD19
|
CD19 molecule
|
1.35
|
|
CLDN4
|
claudin 4
|
1.344
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
1.341
|
|
TP63
|
tumor protein p63
|
1.338
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
1.337
|
|
IFT27
|
intraflagellar transport 27
|
1.335
|
|
FLNA
|
filamin A, alpha
|
1.335
|
|
LMOD1
|
leiomodin 1 (smooth muscle)
|
1.335
|
|
TBX1
|
T-box 1
|
1.331
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
1.329
|
|
SMAD2
|
SMAD family member 2
|
1.329
|
|
CCND1
|
cyclin D1
|
1.328
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
1.325
|
|
SLIT3
|
slit homolog 3 (Drosophila)
|
1.324
|
|
PORCN
|
porcupine homolog (Drosophila)
|
1.322
|
|
NKX3-1
|
NK3 homeobox 1
|
1.322
|
|
PTCH1
|
patched 1
|
1.32
|
|
WDPCP
|
WD repeat containing planar cell polarity effector
|
1.316
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
1.316
|
|
SMAD3
|
SMAD family member 3
|
1.313
|
|
FGF10
|
fibroblast growth factor 10
|
1.311
|
|
HOXA13
|
homeobox A13
|
1.31
|
|
EWSR1
|
EWS RNA-binding protein 1
|
1.309
|
|
MYOD1
|
myogenic differentiation 1
|
1.306
|
|
NKX2-1
|
NK2 homeobox 1
|
1.305
|
|
TAGLN
|
transgelin
|
1.3
|
|
FABP1
|
fatty acid binding protein 1, liver
|
1.299
|
|
SCNN1B
|
sodium channel, non voltage gated 1 beta subunit
|
1.294
|
|
PTEN
|
phosphatase and tensin homolog
|
1.294
|
|
ATP6AP2
|
ATPase, H+ transporting, lysosomal accessory protein 2
|
1.288
|
|
CD163
|
CD163 molecule
|
1.287
|
|
MOCOS
|
molybdenum cofactor sulfurase
|
1.283
|
|
MNX1
|
motor neuron and pancreas homeobox 1
|
1.276
|
|
CCN2
|
cellular communication network factor 2
|
1.275
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
1.275
|
|
SPRY1
|
sprouty homolog 1, antagonist of FGF signaling (Drosophila)
|
1.273
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
1.271
|
|
FGF7
|
fibroblast growth factor 7
|
1.271
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
1.27
|
|
COL4A4
|
collagen, type IV, alpha 4
|
1.266
|
|
EDN1
|
endothelin 1
|
1.263
|
|
TMEM67
|
transmembrane protein 67
|
1.261
|
|
VIM
|
vimentin
|
1.261
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
1.26
|
|
APOL1
|
apolipoprotein L, 1
|
1.26
|
|
MCU
|
mitochondrial calcium uniporter
|
1.258
|
|
NAPSA
|
napsin A aspartic peptidase
|
1.257
|
|
KNG1
|
kininogen 1
|
1.256
|
|
NPHP3
|
nephronophthisis 3 (adolescent)
|
1.255
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
1.255
|
|
KRT19
|
keratin 19, type I
|
1.253
|
|
ITGA8
|
integrin, alpha 8
|
1.252
|
|
EMX2
|
empty spiracles homeobox 2
|
1.251
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
1.247
|
|
PDCD1
|
programmed cell death 1
|
1.244
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
1.243
|
|
SLC3A1
|
solute carrier family 3 (amino acid transporter heavy chain), member 1
|
1.24
|
|
JUN
|
jun proto-oncogene
|
1.238
|
|
DLG1
|
discs, large homolog 1 (Drosophila)
|
1.237
|
|
DSTYK
|
dual serine/threonine and tyrosine protein kinase
|
1.236
|
|
IL2
|
interleukin 2
|
1.235
|
|
LTBP4
|
latent transforming growth factor beta binding protein 4
|
1.234
|
|
MYOCD
|
myocardin
|
1.233
|
|
ACE2
|
angiotensin I converting enzyme 2
|
1.231
|
|
SMAD9
|
SMAD family member 9
|
1.23
|
|
TTC21B
|
tetratricopeptide repeat domain 21B
|
1.228
|
|
ELN
|
elastin
|
1.225
|
|
TBX6
|
T-box 6
|
1.223
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
1.222
|
|
CA2
|
carbonic anhydrase II
|
1.222
|
|
CD207
|
CD207 molecule, langerin
|
1.22
|
|
FGF20
|
fibroblast growth factor 20
|
1.215
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
1.214
|
|
BMPER
|
BMP binding endothelial regulator
|
1.214
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
1.214
|
|
FBN1
|
fibrillin 1
|
1.213
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
1.211
|
|
C16ORF95
|
chromosome 16 open reading frame 95
|
1.209
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
1.209
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
1.208
|
|
BBS7
|
Bardet-Biedl syndrome 7
|
1.208
|
|
DNTT
|
DNA nucleotidylexotransferase
|
1.207
|
|
CUBN
|
cubilin (intrinsic factor-cobalamin receptor)
|
1.207
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
1.206
|
|
COL1A1
|
collagen, type I, alpha 1
|
1.204
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
1.204
|
|
CNOT11
|
CCR4-NOT transcription complex, subunit 11
|
1.202
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
1.199
|
|
FGF9
|
fibroblast growth factor 9
|
1.198
|
|
SMAD4
|
SMAD family member 4
|
1.197
|
|
MYLK
|
myosin light chain kinase
|
1.195
|
|
SLC5A2
|
solute carrier family 5 (sodium/glucose cotransporter), member 2
|
1.194
|
|
IGF2
|
insulin-like growth factor 2
|
1.193
|
|
RARA
|
retinoic acid receptor, alpha
|
1.191
|
|
FOXL1
|
forkhead box L1
|
1.191
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
1.189
|
|
CEP290
|
centrosomal protein 290kDa
|
1.189
|
|
CD38
|
CD38 molecule
|
1.189
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
1.183
|
|
NFIA
|
nuclear factor I/A
|
1.183
|
|
CLCN5
|
chloride channel, voltage-sensitive 5
|
1.178
|
|
GLI1
|
GLI family zinc finger 1
|
1.178
|
|
TSHZ2
|
teashirt zinc finger homeobox 2
|
1.175
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
1.175
|
|
FGF3
|
fibroblast growth factor 3
|
1.174
|
|
CHST14
|
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14
|
1.168
|
|
CREBBP
|
CREB binding protein
|
1.167
|
|
SST
|
somatostatin
|
1.166
|
|
IL1A
|
interleukin 1, alpha
|
1.164
|
|
FREM1
|
FRAS1 related extracellular matrix 1
|
1.164
|
|
EXOC5
|
exocyst complex component 5
|
1.164
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
1.163
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
1.161
|
|
NUMA1
|
nuclear mitotic apparatus protein 1
|
1.159
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
1.158
|
|
TJP1
|
tight junction protein 1
|
1.157
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
1.157
|
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3
|
1.155
|
|
COL4A5
|
collagen, type IV, alpha 5
|
1.155
|
|
NPPA
|
natriuretic peptide A
|
1.153
|
|
BBS5
|
Bardet-Biedl syndrome 5
|
1.153
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
1.151
|
|
THBD
|
thrombomodulin
|
1.146
|
|
GZF1
|
GDNF-inducible zinc finger protein 1
|
1.146
|
|
ZNHIT3
|
zinc finger, HIT-type containing 3
|
1.142
|
|
MAPK8IP2
|
mitogen-activated protein kinase 8 interacting protein 2
|
1.142
|
|
GCG
|
glucagon
|
1.141
|
|
TBC1D3H
|
TBC1 domain family, member 3H
|
1.141
|
|
CDH17
|
cadherin 17, LI cadherin (liver-intestine)
|
1.141
|
|
FGF22
|
fibroblast growth factor 22
|
1.139
|
|
PRL
|
prolactin
|
1.139
|
|
MMP9
|
matrix metallopeptidase 9
|
1.139
|
|
FXYD2
|
FXYD domain containing ion transport regulator 2
|
1.139
|
|
FGF16
|
fibroblast growth factor 16
|
1.138
|
|
FGF6
|
fibroblast growth factor 6
|
1.137
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
1.137
|
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9
|
1.137
|
|
FGF4
|
fibroblast growth factor 4
|
1.134
|
|
CD44
|
CD44 molecule (Indian blood group)
|
1.134
|
|
FGF17
|
fibroblast growth factor 17
|
1.133
|
|
JAG1
|
jagged 1
|
1.131
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
1.13
|
|
FGF18
|
fibroblast growth factor 18
|
1.13
|
|
JAK2
|
Janus kinase 2
|
1.13
|
|
FGF5
|
fibroblast growth factor 5
|
1.13
|
|
BBIP1
|
BBSome interacting protein 1
|
1.129
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
1.127
|
|
NEK8
|
NIMA-related kinase 8
|
1.126
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
1.123
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
1.122
|
|
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
|
1.12
|
|
KRT18
|
keratin 18, type I
|
1.12
|
|
INVS
|
inversin
|
1.119
|
|
ACR
|
acrosin
|
1.119
|
|
NIPBL
|
Nipped-B homolog (Drosophila)
|
1.117
|
|
VWF
|
von Willebrand factor
|
1.117
|
|
ZIC3
|
Zic family member 3
|
1.114
|
|
IL4
|
interleukin 4
|
1.112
|
|
ATP6V0A4
|
ATPase, H+ transporting, lysosomal V0 subunit a4
|
1.112
|
|
SALL4
|
spalt-like transcription factor 4
|
1.11
|
|
KANSL1
|
KAT8 regulatory NSL complex subunit 1
|
1.108
|
|
IL18
|
interleukin 18
|
1.107
|
|
BBS4
|
Bardet-Biedl syndrome 4
|
1.105
|
|
OFD1
|
oral-facial-digital syndrome 1
|
1.105
|
|
BBS9
|
Bardet-Biedl syndrome 9
|
1.104
|
|
PBRM1
|
polybromo 1
|
1.103
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
1.101
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
1.101
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
1.096
|
|
NOTCH2
|
notch 2
|
1.096
|
|
MEN1
|
multiple endocrine neoplasia I
|
1.095
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
1.092
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
1.091
|
|
TRPV5
|
transient receptor potential cation channel, subfamily V, member 5
|
1.091
|
|
PTGES
|
prostaglandin E synthase
|
1.089
|
|
CLTRN
|
collectrin, amino acid transport regulator
|
1.088
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
1.087
|
|
VNN1
|
vanin 1
|
1.086
|
|
FFAR2
|
free fatty acid receptor 2
|
1.086
|
|
IL13
|
interleukin 13
|
1.084
|
|
GLIS2
|
GLIS family zinc finger 2
|
1.084
|
|
HOXD13
|
homeobox D13
|
1.082
|
|
PCDHGB2
|
protocadherin gamma subfamily B, 2
|
1.082
|
|
BGN
|
biglycan
|
1.082
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
1.079
|
|
ETFB
|
electron-transfer-flavoprotein, beta polypeptide
|
1.075
|
|
BRCA1
|
breast cancer 1, early onset
|
1.075
|
|
PCM1
|
pericentriolar material 1
|
1.071
|
|
LMX1B
|
LIM homeobox transcription factor 1, beta
|
1.071
|
|
TSC2
|
tuberous sclerosis 2
|
1.071
|
|
FRYL
|
FRY-like
|
1.069
|
|
OCRL
|
oculocerebrorenal syndrome of Lowe
|
1.069
|
|
MECP2
|
methyl CpG binding protein 2
|
1.067
|
|
WNK4
|
WNK lysine deficient protein kinase 4
|
1.066
|
|
MKS1
|
Meckel syndrome, type 1
|
1.066
|
|
LOC102723407
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
1.066
|
|
MSH6
|
mutS homolog 6
|
1.065
|
|
IFT140
|
intraflagellar transport 140
|
1.065
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
1.065
|
|
DSE
|
dermatan sulfate epimerase
|
1.062
|
|
TRIM8
|
tripartite motif containing 8
|
1.062
|
|
B3GLCT
|
beta 3-glucosyltransferase
|
1.061
|
|
FRY
|
furry homolog (Drosophila)
|
1.06
|
|
ITGB4
|
integrin, beta 4
|
1.06
|
|
SMO
|
smoothened, frizzled class receptor
|
1.06
|
|
DUT-AS1
|
DUT antisense RNA 1
|
1.057
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
1.056
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
1.056
|
|
SLC34A1
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 1
|
1.055
|
|
LEP
|
leptin
|
1.054
|
|
CISD2
|
CDGSH iron sulfur domain 2
|
1.054
|
|
CDC73
|
cell division cycle 73
|
1.048
|
|
CLU
|
clusterin
|
1.047
|
|
DIS3L2
|
DIS3 like 3'-5' exoribonuclease 2
|
1.046
|
|
PIGL
|
phosphatidylinositol glycan anchor biosynthesis, class L
|
1.044
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
1.043
|
|
BICC1
|
BicC family RNA binding protein 1
|
1.042
|
|
LZTS2
|
leucine zipper, putative tumor suppressor 2
|
1.041
|
|
PAX6
|
paired box 6
|
1.04
|
|
CDH6
|
cadherin 6, type 2, K-cadherin (fetal kidney)
|
1.036
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
1.034
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
1.033
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
1.033
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
1.033
|
|
IFT172
|
intraflagellar transport 172
|
1.032
|
|
ARL13B
|
ADP-ribosylation factor-like 13B
|
1.029
|
|
B4GALT7
|
xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7
|
1.028
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
1.028
|
|
CYCS
|
cytochrome c, somatic
|
1.028
|
|
FBLN1
|
fibulin 1
|
1.027
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
1.025
|
|
ATM
|
ATM serine/threonine kinase
|
1.024
|
|
SLC22A12
|
solute carrier family 22 (organic anion/urate transporter), member 12
|
1.023
|
|
DGCR8
|
DGCR8 microprocessor complex subunit
|
1.021
|
|
TMEM11
|
transmembrane protein 11
|
1.018
|
|
FOXP3
|
forkhead box P3
|
1.017
|
|
HDAC9
|
histone deacetylase 9
|
1.016
|
|
OSR2
|
odd-skipped related transciption factor 2
|
1.016
|
|
TLX1
|
T-cell leukemia homeobox 1
|
1.014
|
|
MLH1
|
mutL homolog 1
|
1.013
|
|
PLG
|
plasminogen
|
1.012
|
|
CALB1
|
calbindin 1, 28kDa
|
1.01
|
|
PIGT
|
phosphatidylinositol glycan anchor biosynthesis, class T
|
1.01
|
|
ATP6V1E1
|
ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1
|
1.009
|
|
SCNN1A
|
sodium channel, non voltage gated 1 alpha subunit
|
1.008
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
1.008
|
|
BRCA2
|
breast cancer 2, early onset
|
1.006
|
|
CELSR1
|
cadherin, EGF LAG seven-pass G-type receptor 1
|
1.006
|
|
LBHD2
|
LBH domain containing 2
|
1.004
|
|
MMP2
|
matrix metallopeptidase 2
|
1.003
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
1.002
|
|
AS3MT
|
arsenite methyltransferase
|
1.001
|
|
HSPA4L
|
heat shock 70kDa protein 4-like
|
1.0
|
|
NAA10
|
N(alpha)-acetyltransferase 10, NatA catalytic subunit
|
1.0
|
